Heather Rowe | Senior Director of Investor Relations and Corporate Communications |
Aron Knickerbocker | Chief Executive Officer |
Helen Collins | Senior Vice President, Chief Medical Officer |
Bryan Irving | Chief Scientific Officer |
Linda Rubinstein | Interim Chief Financial Officer |
Nick Abbott | Wells Fargo Securities, LLC |
Greg Harrison | Citi |
Kennen MacKay | RBC Capital Markets |
Eric Joseph | JPMorgan |
Steven Seedhouse | Raymond James & Associates, Inc. |
Robert Driscoll | Wedbush Securities |
Good day, ladies and gentlemen, and welcome to the Five Prime Therapeutics Second Quarter 2018 Earnings Call.
As a reminder, this conference may be recorded. I'd now like to introduce your host for today's conference, Heather Rowe, Senior Director, Investor Relations and Corporate Communications.
You may begin.
Good afternoon and thank you for joining us.